RARE - Ultragenyx - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RARE is currently covered by 18 analysts with an average price target of $73.62. This is a potential upside of $38.01 (106.74%) from yesterday's end of day stock price of $35.61.

Ultragenyx's activity chart (see below) currently has 259 price targets and 246 ratings on display. The stock rating distribution of RARE is 88.89% BUY and 11.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 55.97% with an average time for these price targets to be met of 185.36 days.

Highest price target for RARE is $140, Lowest price target is $48, average price target is $93.5.

Most recent stock forecast was given by JEFFREY HUNG from MORGAN STANLEY on 09-May-2025. First documented stock forecast 25-Feb-2014.

Split History since 2000:

9/3/03 3 for 2

9/6/00 3 for 2

Currently out of the existing stock ratings of RARE, 64 are a BUY (88.89%), 8 are a HOLD (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$65

$29.39 (82.53%)

$67

9 days ago
(09-May-2025)

6/15 (40%)

$29.89 (85.13%)

296

Buy

$117

$81.39 (228.56%)

$102

1 months 21 days ago
(27-Mar-2025)

0/7 (0%)

$78.11 (200.85%)

Buy

$118

$82.39 (231.37%)

$118

2 months 22 days ago
(26-Feb-2025)

0/17 (0%)

$76.38 (183.52%)

Buy

$136

$100.39 (281.92%)

$121

3 months ago
(18-Feb-2025)

0/9 (0%)

$93.51 (220.08%)

Buy

$95

$59.39 (166.78%)

$95

3 months ago
(18-Feb-2025)

0/5 (0%)

$52.51 (123.58%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RARE (Ultragenyx) average time for price targets to be met?

On average it took 185.36 days on average for the stock forecasts to be realized with a an average price target met ratio 55.97

Which analyst has the current highest performing score on RARE (Ultragenyx) with a proven track record?

MARTIN AUSTER

Which analyst has the most public recommendations on RARE (Ultragenyx)?

Martin Auster has 8 price targets and 5 ratings on RARE

Which analyst is the currently most bullish on RARE (Ultragenyx)?

Maury Raycroft with highest potential upside - $145.39

Which analyst is the currently most reserved on RARE (Ultragenyx)?

Arlinda Lee with lowest potential downside - -$0

Ultragenyx in the News

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shareholders are probably feeling a little disappointed, since its shares fell 7.7% to US$35.98 in the week after its latest first-quarter results. Revenues of US$139m came in 3.6% below estimates, but statutory losses were slightly better than expected, at US$1.57 per share. Earnings are an important time for investors, as they...

Ultragenyx price target lowered to $100 from $140 at Truist

Truist lowered the firm’s price target on Ultragenyx (RARE) to $100 from $140 and keeps a Buy rating on the shares. The company’s Q1 results were in-line and the management reiterated its FY25 revenue guidance, though the firm’s price target is cut on tampered outlook for gene therapy programs, the analyst tells investors in a...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?